🇺🇸 Roflumilast alternated days in United States

Roflumilast alternated days (Roflumilast alternated days) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Roflumilast alternated days in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Roflumilast alternated days approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Roflumilast alternated days in United States?

Fundación Pública Andaluza Progreso y Salud is the originator. The local marketing authorisation holder may differ — check the official source linked above.